These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 12759327)

  • 21. Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading?
    Hernández AV; Boersma E; Murray GD; Habbema JD; Steyerberg EW
    Am Heart J; 2006 Feb; 151(2):257-64. PubMed ID: 16442886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statistical power, sample size, and their reporting in randomized controlled trials.
    Moher D; Dulberg CS; Wells GA
    JAMA; 1994 Jul; 272(2):122-4. PubMed ID: 8015121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of clinical practice guidelines on patient outcomes in primary care: a systematic review.
    Worrall G; Chaulk P; Freake D
    CMAJ; 1997 Jun; 156(12):1705-12. PubMed ID: 9220922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reporting of time-to-event end points and tracking of failures in randomized trials of radiotherapy with or without any concomitant anticancer agent for locally advanced head and neck cancer.
    Le Tourneau C; Michiels S; Gan HK; Siu LL
    J Clin Oncol; 2009 Dec; 27(35):5965-71. PubMed ID: 19805677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low rate of sex-specific result reporting in cardiovascular trials.
    Blauwet LA; Hayes SN; McManus D; Redberg RF; Walsh MN
    Mayo Clin Proc; 2007 Feb; 82(2):166-70. PubMed ID: 17290722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interpretation of CIs in clinical trials with non-significant results: systematic review and recommendations.
    Gewandter JS; McDermott MP; Kitt RA; Chaudari J; Koch JG; Evans SR; Gross RA; Markman JD; Turk DC; Dworkin RH
    BMJ Open; 2017 Jul; 7(7):e017288. PubMed ID: 28720618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The quality of reports of randomized trials in multiple sclerosis: a review.
    Signori A; Baccino A; Sormani MP
    Mult Scler; 2012 Jun; 18(6):776-81. PubMed ID: 22495947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the global statistical test and composite outcome for secondary analyses of multiple coronary heart disease outcomes.
    Baraniuk S; Seay R; Sinha AK; Piller LB
    Prog Cardiovasc Dis; 2012; 54(4):357-61. PubMed ID: 22226004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reporting of gender-related information in clinical trials of drug therapy for myocardial infarction.
    Rochon PA; Clark JP; Binns MA; Patel V; Gurwitz JH
    CMAJ; 1998 Aug; 159(4):321-7. PubMed ID: 9732709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Easily applicable multiple testing procedures to improve the interpretation of clinical trials with composite endpoints.
    Schüler S; Mucha A; Doherty P; Kieser M; Rauch G
    Int J Cardiol; 2014 Jul; 175(1):126-32. PubMed ID: 24861257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statistical considerations for use of composite health-related quality-of-life scores in randomized trials.
    Vickers AJ
    Qual Life Res; 2004 May; 13(4):717-23. PubMed ID: 15129882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The quality of reporting of trial abstracts is suboptimal: survey of major general medical journals.
    Berwanger O; Ribeiro RA; Finkelsztejn A; Watanabe M; Suzumura EA; Duncan BB; Devereaux PJ; Cook D
    J Clin Epidemiol; 2009 Apr; 62(4):387-92. PubMed ID: 19010643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How well is the clinical importance of study results reported? An assessment of randomized controlled trials.
    Chan KB; Man-Son-Hing M; Molnar FJ; Laupacis A
    CMAJ; 2001 Oct; 165(9):1197-202. PubMed ID: 11706908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicenter, randomized, controlled trials evaluating mortality in intensive care: doomed to fail?
    Ospina-Tascón GA; Büchele GL; Vincent JL
    Crit Care Med; 2008 Apr; 36(4):1311-22. PubMed ID: 18379260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.
    Chan AW; Hróbjartsson A; Haahr MT; Gøtzsche PC; Altman DG
    JAMA; 2004 May; 291(20):2457-65. PubMed ID: 15161896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trials--multiple treatments, multiple end points, and multiple lessons.
    Lauer MS; Topol EJ
    JAMA; 2003 May; 289(19):2575-7. PubMed ID: 12759328
    [No Abstract]   [Full Text] [Related]  

  • 37. Annals of Emergency Medicine Journal Club. Outcome measures, interim analyses, and Bayesian approaches to randomized trials: answers to the September 2009 Journal Club questions.
    Brown AM; Schriger DL; Barrett TW
    Ann Emerg Med; 2010 Feb; 55(2):216-224.e1. PubMed ID: 20116032
    [No Abstract]   [Full Text] [Related]  

  • 38. Dealing with heterogeneity of treatment effects: is the literature up to the challenge?
    Gabler NB; Duan N; Liao D; Elmore JG; Ganiats TG; Kravitz RL
    Trials; 2009 Jun; 10():43. PubMed ID: 19545379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early stopping of prevention trials when multiple outcomes are of interest: a discussion.
    Green SB; Freedman LS
    Stat Med; 1994 Jul 15-30; 13(13-14):1479-84. PubMed ID: 7973227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Composite End Points in Acute Heart Failure Research: Data Simulations Illustrate the Limitations.
    Brown PM; Anstrom KJ; Felker GM; Ezekowitz JA
    Can J Cardiol; 2016 Nov; 32(11):1356.e21-1356.e28. PubMed ID: 27499377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.